Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Camp4 Therapeutics (CAMP) Cash from Operations (2023 - 2026)

Camp4 Therapeutics' Cash from Operations history spans 3 years, with the latest figure at 6247000.0 for Q4 2025.

  • On a quarterly basis, Cash from Operations rose 155.34% to 6247000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was 29553000.0, a 35.14% increase, with the full-year FY2025 number at 29553000.0, up 35.14% from a year prior.
  • Cash from Operations hit 6247000.0 in Q4 2025 for Camp4 Therapeutics, up from 11200000.0 in the prior quarter.
  • Over the last five years, Cash from Operations for CAMP hit a ceiling of 6247000.0 in Q4 2025 and a floor of 14286000.0 in Q1 2025.
  • Historically, Cash from Operations has averaged 9655333.33 across 3 years, with a median of 11200000.0 in 2025.
  • The widest YoY moves for Cash from Operations: up 155.34% in 2025, down 28.21% in 2025.
  • Tracing CAMP's Cash from Operations over 3 years: stood at 11783000.0 in 2023, then grew by 4.2% to 11288000.0 in 2024, then surged by 155.34% to 6247000.0 in 2025.
  • Business Quant data shows Cash from Operations for CAMP at 6247000.0 in Q4 2025, 11200000.0 in Q3 2025, and 10314000.0 in Q2 2025.